Cambridge, Massachusetts-based Moderna, is trying to develop a new kind of drug and vaccine using the body’s own cellular machinery to protect against or even fight off disease.
The company develops drugs for the treatment of infectious diseases, genetic disorders, cancer and cardiovascular diseases, by using its novel messenger RNA technology to convey genetic information within cells.
Messenger RNA, or mRNA, plays a fundamental role in human biology, transferring the instructions stored in DNA to make the proteins required in every living cell. The company's approach is to use mRNA medicines to instruct a patient’s own cells to produce proteins that could prevent, treat, or cure disease.
It’s partners include heavy hitters like AstraZeneca PLC (NYSE:AZN), Merck & Co Inc (NYSE:MRK) and Vertex Pharmaceuticals Inc (NASDAQ:VRTX).